Eyenovia, Inc. Banner Image

Eyenovia, Inc.

  • Ticker EYEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eyenovia, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.
Eyenovia, Inc.

Most Recent Annual Report

Eyenovia, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports